New reimbursement regulations face backlash

The government's plan to set up new regulations aiming to cut prices of pharmaceutical products and control soaring health insurance expenditures has trigged a backlash from the domestic pharmaceutical industry.

The Korea Pharmaceutical Manufacturers Association (KPMA) claims the new system could threaten the competitiveness of domestic pharmaceutical companies, saying that under the new sys...